Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 113

1.
4.

Mode of action of SDZ NIM 811, a nonimmunosuppressive cyclosporin A analog with activity against human immunodeficiency virus type 1 (HIV-1): interference with early and late events in HIV-1 replication.

Steinkasserer A, Harrison R, Billich A, Hammerschmid F, Werner G, Wolff B, Peichl P, Palfi G, Schnitzel W, Mlynar E, et al.

J Virol. 1995 Feb;69(2):814-24.

5.

Modulation of HIV-1 infectivity and cyclophilin A-dependence by Gag sequence and target cell type.

Matsuoka S, Dam E, Lecossier D, Clavel F, Hance AJ.

Retrovirology. 2009 Mar 2;6:21. doi: 10.1186/1742-4690-6-21.

6.
7.
9.

Inhibitors of human immunodeficiency virus type 1 zinc fingers prevent normal processing of gag precursors and result in the release of noninfectious virus particles.

Turpin JA, Terpening SJ, Schaeffer CA, Yu G, Glover CJ, Felsted RL, Sausville EA, Rice WG.

J Virol. 1996 Sep;70(9):6180-9.

10.

Gag protein from human immunodeficiency virus type 1 assembles in the absence of cyclophilin A.

Streblow DN, Kitabwalla M, Pauza CD.

Virology. 1998 Dec 5;252(1):228-34.

11.

Target cell cyclophilin A modulates human immunodeficiency virus type 1 infectivity.

Sokolskaja E, Sayah DM, Luban J.

J Virol. 2004 Dec;78(23):12800-8.

13.
15.

A synthetic HIV-1 protease inhibitor with antiviral activity arrests HIV-like particle maturation.

[No authors listed]

Dis Markers. 1990 May-Jun;8(3):162-3. No abstract available.

PMID:
2125537
16.
19.
Items per page

Supplemental Content

Write to the Help Desk